James H. Stanker - Apr 5, 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Financial Officer
Signature
/s/ James H. Stanker by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Apr 5, 2024
Transactions value $
-$1,927
Form type
4
Date filed
8/2/2024, 05:31 PM
Previous filing
Apr 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1.68K +33.75% 6.64K Apr 5, 2024 Direct F1
transaction PCSA Common Stock Tax liability -$1.45K -518 -7.8% $2.79 6.12K Apr 5, 2024 Direct
transaction PCSA Common Stock Options Exercise +644 +10.52% 6.76K Jul 10, 2024 Direct F1
transaction PCSA Common Stock Tax liability -$482 -282 -4.17% $1.71 6.48K Jul 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +3.08K +13.15% $0.00 26.5K Jun 28, 2024 Common Stock 3.08K $0.00 Direct F2
transaction PCSA Restricted Stock Units Award $0 +2.31K +8.72% $0.00 28.8K Jun 28, 2024 Common Stock 2.31K $0.00 Direct F3
transaction PCSA Restricted Stock Units Award $0 +385 +1.34% $0.00 29.2K Jun 28, 2024 Common Stock 385 $0.00 Direct F4
transaction PCSA Restricted Stock Units Award $0 +385 +1.32% $0.00 29.5K Jun 28, 2024 Common Stock 385 $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.